Clinical value of TV-CDS combined with serum tumor markers in diagnosis of ovarian cancer

被引:11
|
作者
Yu, Chunying [1 ]
Dou, Ting [1 ]
Liu, Yun [1 ]
Liu, Ruirong [1 ]
机构
[1] Third Peoples Hosp Qingdao, Dept Ultrason Med, 29 Yongping Rd, Qingdao 266041, Shandong, Peoples R China
关键词
ovarian cancer; color doppler ultrasound; transvaginal; tumor markers; serology; combined examination; DOPPLER SONOGRAPHY; OSTEOPONTIN; STAGE; DISCRIMINATION; ULTRASOUND; CA125;
D O I
10.3892/ol.2020.11705
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clinical application value was investigated of transvaginal color Doppler ultrasound (TV-CDS) combined with serum tumor markers carbohydrate antigen 125 (CA125), vascular endothelial growth factor (VEGF) and osteopontin (OPN) in the diagnosis of ovarian cancer (OC). One hundred and six patients with OC [malignant tumor group (MTG)] and fifty patients with benign ovarian diseases [benign control group (BCG)] were selected. Both groups of patients underwent TV-CDS examination. The lesion morphology and internal structure were observed, and the tumor blood flow signal, resistance index (RI) and pulsability index (PI) under ultrasound were determined. Serum CA125 was detected by electrochemiluminescence, and VEGF and OPN levels were detected by enzyme-linked immunosorbent assay. The incidence of irregular lesion morphology, unclear boundary, uneven internal echo, microcalcification and side-acoustic images in OC group (OCG) was significantly higher than that in BCG (P<0.01). As for blood flow grading, most patients in the MTG were in grade II and III, while most patients in the BCG were in grade 0. Compared with BCG, the flow RI and PI in the OCG were significantly reduced (P<0.01). The levels of serum CA125, VEGF and OPN in OCG were significantly higher than those in BCG. The expression levels of serum CA125, VEGF and OPN in OC patients with clinical high stage (stage III and IV), poorly differentiated, ascites, recurrence and metastasis were significantly higher than those in patients with clinical low stage (stage I and II), well differentiated, no ascites and no recurrence and metastasis (P<0.05). With the disappearance of the tumor or the decrease of tumor load, the serum marker levels after treatment were significantly lower than that before treatment (P<0.05). The sensitivity and accuracy of the combined examination in the diagnosis of OC were obviously improved compared with the single and partial combined examinations (P<0.05). In conclusion, combined examination can significantly improve the sensitivity and accuracy of OC, which is conducive to early diagnosis and clinical intervention of OC.
引用
收藏
页码:2028 / 2034
页数:7
相关论文
共 50 条
  • [31] The clinical value of tumour markers in the management of ovarian cancer
    Rustin, GJS
    ANNALS OF CLINICAL BIOCHEMISTRY, 1996, 33 : 284 - 289
  • [32] Application Value of Combined Detection of DCE-MRI and Serum Tumor Markers HE4, Ki67, and HK10 in the Diagnosis of Ovarian Cancer
    Wang, Quanzhi
    Dong, Hui
    Zhou, Peng
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
  • [33] Investigation of Serum Tumor Markers in the Diagnosis of Gastric Cancer
    Fan, Biao
    Xiong, Bin
    HEPATO-GASTROENTEROLOGY, 2011, 58 (105) : 239 - 245
  • [34] The Value of Ultrasonography and Tumor Markers in the Differential Diagnosis of Postmenopausal Ovarian Cysts
    Avsar, Filiz
    Simsek, Emel
    Isenlik, Sitki
    Uzun, Mustafa
    Ozyigit, Eda
    Cinkaya, Ayseguel
    Gumus, Mehmet
    Celen, Emine
    Ustuner, Isik
    Keskin, Levent
    Aydogmus, Serpil
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2009, 39 (02) : 179 - 183
  • [35] Serum tumor markers in the management of ovarian, endometrial and cervical cancer
    Gadducci, A
    Cosio, S
    Carpi, A
    Nicolini, A
    Genazzani, AR
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (01) : 24 - 38
  • [36] RELATION OF BMI AND SERUM TUMOR MARKERS TO CASES OF OVARIAN CANCER
    Filipova, I.
    Chakalova, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 : 59 - 59
  • [37] Study on the application value of combined detection of multiple tumor markers in lung cancer classification diagnosis
    Zhou, R. M.
    Cai, Z. H.
    Yuan, YR.
    Zhou, Z. L.
    Ding, H.
    Cheng, Y. Q.
    Liang, L.
    Tuo, Z. N.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2024, 22 (02):
  • [38] Comparison of serum tumor markers combined with dual-source CT in the diagnosis of lung cancer
    Shan, Yuqing
    Yin, Xiangyuan
    Zhao, Na
    Wang, Jie
    Yang, Shouxiang
    MINERVA MEDICA, 2023, 114 (06) : 795 - 801
  • [39] Clinical Observations on the Association Between Diagnosis of Lung Cancer and Serum Tumor Markers in Combination
    Wang, Wen-Jing
    Tao, Zhen
    Gu, Wei
    Sun, Li-Hua
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) : 4369 - 4371
  • [40] Prognostic value of serum tumor markers in patients with lung cancer
    Hatzakis, KD
    Froudarakis, ME
    Bouros, D
    Tzanakis, N
    Karkavitsas, N
    Siafakasa, NM
    RESPIRATION, 2002, 69 (01) : 25 - 29